A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)

Dirk Rades; Carlos A. Narvaez; Laura Splettstößer; Claudia Dömer; Cornelia Setter; Christian Idel; Julika Ribbat-Idel; Sven Perner; Tobias Bartscht; Denise Olbrich; Steven E. Schild; Jesper Carl

doi:10.1016/j.radonc.2019.07.023

A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)

Dirk Rades^*, Carlos A. Narvaez, Laura Splettstößer, Claudia Dömer, Cornelia Setter, Christian Idel, Julika Ribbat-Idel, Sven Perner, Tobias Bartscht, Denise Olbrich, Steven E. Schild, Jesper Carl

^*Korrespondierende/r Autor/-in für diese Arbeit

35 Zitate (Scopus)

Abstract

Mepitel® Film (MEP) and standard care (STD) were compared for radiation dermatitis in SCCHN patients. This trial was stopped prematurely since13/28 patients did not tolerate MEP. Grade ≥2 dermatitis: 34.8% (MEP) vs. 35.7% (STD) at 50 Gy, 65.2% vs. 59.3% at 60 Gy. MEP was unsatisfactorily tolerated and appeared not superior (NCT03047174).

Originalsprache	Englisch
Zeitschrift	Radiotherapy and Oncology
Jahrgang	139
Seiten (von - bis)	79-82
Seitenumfang	4
ISSN	0167-8140
DOIs	https://doi.org/10.1016/j.radonc.2019.07.023
Publikationsstatus	Veröffentlicht - 10.2019

Fördermittel

As part of the project InnoCan, the RAREST-01 study was funded by the European Regional Development Fund through the Interreg Deutschland-Danmark program (reference: Innoc 11-1.0-15). The funding body has no role in the design of the study, in collection, analysis and interpretation of the data and in writing of the manuscript.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Dokumente

10.1016/j.radonc.2019.07.023

Weitere Links

Link to publication in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren

Rades, D., Narvaez, C. A., Splettstößer, L., Dömer, C., Setter, C., Idel, C., Ribbat-Idel, J., Perner, S., Bartscht, T., Olbrich, D., Schild, S. E., & Carl, J. (2019). A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). Radiotherapy and Oncology, 139, 79-82. https://doi.org/10.1016/j.radonc.2019.07.023

@article{e0da01c130dc4791ba7ba9d800581a35,

title = "A randomized trial (RAREST-01) comparing Mepitel{\textregistered} Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)",

abstract = "Mepitel{\textregistered} Film (MEP) and standard care (STD) were compared for radiation dermatitis in SCCHN patients. This trial was stopped prematurely since13/28 patients did not tolerate MEP. Grade ≥2 dermatitis: 34.8\% (MEP) vs. 35.7\% (STD) at 50 Gy, 65.2\% vs. 59.3\% at 60 Gy. MEP was unsatisfactorily tolerated and appeared not superior (NCT03047174).",

author = "Dirk Rades and Narvaez, \{Carlos A.\} and Laura Splettst{\"o}{\ss}er and Claudia D{\"o}mer and Cornelia Setter and Christian Idel and Julika Ribbat-Idel and Sven Perner and Tobias Bartscht and Denise Olbrich and Schild, \{Steven E.\} and Jesper Carl",

year = "2019",

month = oct,

doi = "10.1016/j.radonc.2019.07.023",

language = "English",

volume = "139",

pages = "79--82",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

Rades, D , Narvaez, CA, Splettstößer, L, Dömer, C, Setter, C, Idel, C, Ribbat-Idel, J, Perner, S , Bartscht, T , Olbrich, D, Schild, SE & Carl, J 2019, 'A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)', Radiotherapy and Oncology, Jg. 139, S. 79-82. https://doi.org/10.1016/j.radonc.2019.07.023

A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). / Rades, Dirk ; Narvaez, Carlos A.; Splettstößer, Laura et al.
in: Radiotherapy and Oncology, Jahrgang 139, 10.2019, S. 79-82.

Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

TY - JOUR

T1 - A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)

AU - Rades, Dirk

AU - Narvaez, Carlos A.

AU - Splettstößer, Laura

AU - Dömer, Claudia

AU - Setter, Cornelia

AU - Idel, Christian

AU - Ribbat-Idel, Julika

AU - Perner, Sven

AU - Bartscht, Tobias

AU - Olbrich, Denise

AU - Schild, Steven E.

AU - Carl, Jesper

PY - 2019/10

Y1 - 2019/10

N2 - Mepitel® Film (MEP) and standard care (STD) were compared for radiation dermatitis in SCCHN patients. This trial was stopped prematurely since13/28 patients did not tolerate MEP. Grade ≥2 dermatitis: 34.8% (MEP) vs. 35.7% (STD) at 50 Gy, 65.2% vs. 59.3% at 60 Gy. MEP was unsatisfactorily tolerated and appeared not superior (NCT03047174).

AB - Mepitel® Film (MEP) and standard care (STD) were compared for radiation dermatitis in SCCHN patients. This trial was stopped prematurely since13/28 patients did not tolerate MEP. Grade ≥2 dermatitis: 34.8% (MEP) vs. 35.7% (STD) at 50 Gy, 65.2% vs. 59.3% at 60 Gy. MEP was unsatisfactorily tolerated and appeared not superior (NCT03047174).

UR - https://www.scopus.com/pages/publications/85070690069

U2 - 10.1016/j.radonc.2019.07.023

DO - 10.1016/j.radonc.2019.07.023

M3 - Journal articles

C2 - 31431372

AN - SCOPUS:85070690069

SN - 0167-8140

VL - 139

SP - 79

EP - 82

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -